CN Stock MarketDetailed Quotes
605033 Shaanxi Meibang Pharmaceutical Group
- 12.96
- +0.30+2.37%
Market Closed Dec 20 15:00 CST
1.75BMarket Cap57.09P/E (TTM)
13.05High12.56Low17.47KlotVolume12.79Open12.66Pre Close22.53MTurnover1.29%Turnover Ratio30.42P/E (Static)135.20MShares19.0552wk High1.55P/B1.75BFloat Cap9.6952wk Low13.93Limit Up135.20MShs Float30.22Historical High11.39Limit Down3.87%Amplitude9.69Historical Low0.20Dividend TTM12.90Avg Price8.30KlotAsk1.50%Div YieldTTM100Lot Size8.64KlotBid
Shaanxi Meibang Pharmaceutical Group Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 12.49%622.78M | 7.03%509.61M | -9.46%312.09M | -22.85%699.03M | -19.06%553.64M | -22.91%476.15M | -29.30%344.71M | 7.54%906.05M | 24.27%684.02M | 29.71%617.65M |
| Operating revenue | 12.49%622.78M | 7.03%509.61M | -9.46%312.09M | -22.85%699.03M | -19.06%553.64M | -22.91%476.15M | -29.30%344.71M | 7.54%906.05M | 24.27%684.02M | 29.71%617.65M |
| Other operating revenue | ---- | -25.72%3.5M | ---- | 689.11%5.01M | ---- | 725.17%4.72M | ---- | 12.59%634.62K | ---- | -1.31%571.67K |
| Total operating cost | 23.37%579.02M | 19.42%456.22M | 1.21%262.95M | -15.15%639.65M | -15.38%469.34M | -18.66%382.03M | -28.17%259.8M | 6.91%753.87M | 18.98%554.66M | 23.59%469.69M |
| Operating cost | 21.63%431.27M | 19.86%355M | 1.65%212.89M | -11.36%459.93M | -9.24%354.56M | -16.07%296.18M | -24.82%209.44M | -0.23%518.86M | 10.27%390.67M | 14.33%352.9M |
| Operating tax surcharges | 71.40%3.95M | 68.83%2.7M | 31.76%1.16M | -0.99%3.41M | -3.87%2.31M | -8.70%1.6M | -32.52%882.05K | 18.97%3.45M | 16.34%2.4M | 16.59%1.75M |
| Operating expense | 14.98%65.97M | 16.13%46.96M | 8.74%23.88M | -30.35%85.42M | -31.96%57.38M | -36.41%40.44M | -54.50%21.96M | 38.95%122.65M | 55.70%84.33M | 97.45%63.59M |
| Administration expense | 20.71%27.51M | 11.59%17.39M | -0.77%8.39M | 10.87%33.85M | -14.00%22.79M | 5.42%15.58M | -4.60%8.45M | 7.37%30.53M | 86.95%26.5M | 65.59%14.78M |
| Financial expense | -5.61%-1.14M | -0.07%-865.88K | 53.66%-397.44K | 10.06%-1.49M | 15.14%-1.08M | 26.95%-865.24K | 12.26%-857.58K | -199.15%-1.66M | -196.68%-1.27M | -477.29%-1.18M |
| -Interest expense (Financial expense) | -97.40%9.48K | -97.33%9.48K | --8.33K | -61.67%375.41K | -49.11%364.79K | 26.06%355.2K | --0 | -70.38%979.49K | -65.16%716.77K | -41.85%281.78K |
| -Interest Income (Financial expense) | 20.01%-1.21M | 28.11%-911.65K | 52.58%-421.42K | 27.39%-2M | 26.51%-1.52M | 15.23%-1.27M | 20.22%-888.73K | -61.50%-2.75M | -147.91%-2.06M | -529.48%-1.5M |
| Research and development | 54.14%51.45M | 20.43%35.03M | -14.53%17.03M | -26.88%58.53M | -35.85%33.38M | -23.13%29.09M | -22.35%19.93M | 25.45%80.04M | 29.54%52.03M | 33.13%37.84M |
| Credit Impairment Loss | -5.78%-3.62M | -46.83%-12.76M | 8.19%-6.35M | 141.23%2.47M | 66.39%-3.43M | 47.18%-8.69M | 57.80%-6.92M | -73.98%-5.99M | -34.13%-10.19M | -25.75%-16.45M |
| Asset Impairment Loss | -820.08%-5.56M | -1,364.55%-4.9M | -247.05%-747.54K | -81.84%-18.11M | 110.78%771.48K | 95.87%-334.72K | 112.50%508.34K | 19.11%-9.96M | -222.62%-7.16M | -114.06%-8.11M |
| Other net revenue | 10,308.60%5.11M | 31.36%-4.87M | 107.38%415.68K | 24.36%-9M | 99.64%-50.04K | 67.41%-7.1M | 70.17%-5.64M | 19.81%-11.91M | -54.25%-13.83M | -35.79%-21.79M |
| Fair value change income | 1,712.13%1.23M | 1,483.47%1.07M | --0 | --0 | --67.76K | --67.76K | --67.76K | ---67.76K | ---- | --0 |
| Invest income | 65.93%4.21M | 65.96%3.08M | 75.42%1.24M | 11.47%4.58M | -27.97%2.54M | -33.08%1.86M | -54.95%708.95K | 352.43%4.11M | 313.59%3.52M | 236.08%2.77M |
| Other revenue | --8.85M | --8.63M | --6.27M | --2.06M | ---- | ---- | ---- | ---- | ---- | ---- |
| Operating profit | -41.99%48.87M | -44.25%48.51M | -37.49%49.55M | -64.09%50.37M | -27.08%84.25M | -31.03%87.02M | -25.90%79.27M | 14.51%140.27M | 53.41%115.54M | 57.52%126.17M |
| Add:Non operating Income | 10.78%2.4M | -2.69%1.68M | -96.90%23.18K | -11.22%12.35M | -81.70%2.17M | -83.63%1.72M | 52.79%748.63K | -16.88%13.91M | 1,511.94%11.85M | 1,566.35%10.52M |
| Less:Non operating expense | -87.52%19.64K | -94.32%7.56K | -99.26%548.17 | -82.90%311.34K | -81.40%157.34K | -81.53%133.07K | -86.31%73.69K | 341.72%1.82M | 296.43%846.08K | 261.39%720.36K |
| Total profit | -40.58%51.26M | -43.37%50.18M | -37.99%49.57M | -59.04%62.41M | -31.83%86.26M | -34.83%88.61M | -25.24%79.95M | 9.75%152.37M | 66.87%126.54M | 68.84%135.97M |
| Less:Income tax cost | -50.34%7.98M | -81.65%2.75M | -51.87%5.14M | -33.33%4.85M | 8.84%16.07M | -21.03%15M | -29.72%10.67M | -44.38%7.28M | 21.99%14.76M | 71.27%18.99M |
| Add:Adjusted items effecting net profit | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0.01 |
| Net profit | -38.34%43.28M | -35.57%47.43M | -35.85%44.44M | -60.33%57.56M | -37.20%70.19M | -37.07%73.61M | -24.50%69.28M | 15.38%145.09M | 75.39%111.77M | 68.45%116.98M |
| Net profit from continuing operation | -38.34%43.28M | -35.57%47.43M | -35.85%44.44M | -60.33%57.56M | -37.20%70.19M | -37.07%73.61M | -24.50%69.28M | 15.38%145.09M | 75.39%111.77M | 68.45%116.98M |
| Net profit of parent company owners | -38.34%43.28M | -35.57%47.43M | -35.85%44.44M | -60.33%57.56M | -37.20%70.19M | -37.07%73.61M | -24.50%69.28M | 15.38%145.09M | 75.39%111.77M | 68.45%116.98M |
| Earning per share | ||||||||||
| Basic earning per share | -38.46%0.32 | -35.19%0.35 | -35.29%0.33 | -59.81%0.43 | -36.59%0.52 | -37.93%0.54 | -25.00%0.51 | -6.14%1.07 | 30.16%0.82 | 27.94%0.87 |
| Diluted earning per share | -38.46%0.32 | -35.19%0.35 | -35.29%0.33 | -59.81%0.43 | -36.59%0.52 | -37.93%0.54 | -25.00%0.51 | -6.14%1.07 | 30.16%0.82 | 27.94%0.87 |
| Other composite income | ||||||||||
| Total composite income | -38.34%43.28M | -35.57%47.43M | -35.85%44.44M | -60.33%57.56M | -37.20%70.19M | -37.07%73.61M | -24.50%69.28M | 15.38%145.09M | 75.39%111.77M | 68.45%116.98M |
| Total composite income of parent company owners | -38.34%43.28M | -35.57%47.43M | -35.85%44.44M | -60.33%57.56M | -37.20%70.19M | -37.07%73.61M | -24.50%69.28M | 15.38%145.09M | 75.39%111.77M | 68.45%116.98M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data